Drug Discovery & Development

After reviewing DNA evidence from a cold case murder, Kirsty Wright uncovered systemic flaws and deception in a forensics laboratory in Queensland, Australia.

Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology lifeline.

A series of rodent experiments showed that even with abundant food and water, personal space is essential to prevent societal collapse, but Universe 25's relevance to humans remains disputed.

Studying over 100,000 embryos revealed genetic factors behind chromosome segregation issues that lead to aneuploidy, informing future risk screening and intervention.

Phenotypic 3D cell models incorporate tissue architectures and extracellular matrices to recapitulate the complexity of the in vivo microenvironment.

In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.